MMSI Executive Chairman reports 10,000-share sale and option holdings
Rhea-AI Filing Summary
Merit Medical Systems (MMSI) reported an insider transaction by a director and Executive Chairman. On 11/25/2025, the insider sold 10,000 shares of common stock at a weighted average price of $88.0377, with individual trades between $88.00 and $88.175. After the sale, the insider directly owned 1,019,955 shares of common stock.
The insider also had indirect holdings of 8,280.258 shares through a spouse, 98,132 shares through a 401(k) plan as of 10/31/2025, and 90 shares held by the spouse as custodian for a child. In addition, the insider held non-qualified stock options to purchase 100,334 shares at $37.71 expiring on 02/26/2027, 58,083 shares at $56.25 expiring on 03/19/2028, and 54,302 shares at $70.58 expiring on 02/28/2030, each vesting in 25% annual installments from their respective commencement dates.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, No Par Value | 10,000 | $88.0377 | $880K |
| holding | Non-qualified stock options (right to buy) | -- | -- | -- |
| holding | Non-qualified stock options (right to buy) | -- | -- | -- |
| holding | Non-qualified stock options (right to buy) | -- | -- | -- |
| holding | Common Stock, No Par Value | -- | -- | -- |
| holding | Common Stock, No Par Value | -- | -- | -- |
| holding | Common Stock, No Par Value | -- | -- | -- |
Footnotes (1)
- Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse. The 401(k) number represents plan holdings as of 10/31/2025. The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.00 to $88.175, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Becomes exercisable in equal annual installments of 25% commencing 2/26/2021. Becomes exercisable in equal annual installments of 25% commencing 3/19/2022. Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.
FAQ
What insider transaction did Merit Medical Systems (MMSI) report on this Form 4?
The filing shows that a director and Executive Chairman of Merit Medical Systems sold 10,000 shares of common stock on 11/25/2025.
What stock options does the MMSI insider hold according to this Form 4?
The insider holds non-qualified stock options for 100,334 shares at $37.71 expiring on 02/26/2027, 58,083 shares at $56.25 expiring on 03/19/2028, and 54,302 shares at $70.58 expiring on 02/28/2030, each vesting in 25% annual installments from its commencement date.
How does the Form 4 describe the vesting of the MMSI insider’s stock options?
Each non-qualified stock option grant becomes exercisable in equal annual installments of 25%, commencing on 02/26/2021, 03/19/2022, and 02/28/2024, respectively.